Enveric Biosciences, Inc.

NASDAQ (USD): Enveric Biosciences, Inc. (ENVB)

Last Price

1.74

Today's Change

-0.07 (3.86%)

Day's Change

1.62 - 1.79

Trading Volume

1,909,024

Overview

Market Cap

1 Million

Shares Outstanding

692,580

Avg Volume

70,784

Avg Price (50 Days)

69.92

Avg Price (200 Days)

118.74

PE Ratio

-0.05

EPS

-36.30

Earnings Announcement

24-Mar-2025

Previous Close

1.81

Open

1.73

Day's Range

1.62 - 1.79

Year Range

1.62 - 657.0

Trading Volume

1,917,011

Price Change Highlight

1 Day Change

-3.87%

5 Day Change

-59.35%

1 Month Change

-71.24%

3 Month Change

-75.00%

6 Month Change

-79.65%

Ytd Change

-70.26%

1 Year Change

-86.51%

3 Year Change

-99.63%

5 Year Change

-99.96%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment